Defibrillator Market by Product (Tranvenous ICD (Single & dual chamber, biventricular, CRT-D), Subcutaneous, External (Automated, Wearable)), Patient (Adult, Pediatric), Enduser (Hospitals, Prehospital, Home care, Public Access) - Global Forecast to 2028
The global defibrillators market is expected to reach USD 18.1 billion by 2028 from USD 13.6 billion in 2023, at a CAGR of 5.9% during the forecast period. The increase in the demand for defibrillators market is driven by the increasing population proportion with cardiovascular diseases, technological advancements in defibrillators, and rising initiatives by public & private organizations to provide free training & programs and enhance the implementation of public access defibrillators (PADs). However, issues related to implantable and automated external defibrillators and frequent product recalls impeded market growth.
'Implantable Cardioverter Defibrillator segment accounted for the largest share of global defibrillator market in 2022'
Based on product , the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. ICDs are further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual AED, fully automated AED, and wearable defibrillator. The ICDs segment accounted for the largest global defibrillators market share in 2022. The technological advancements in implantable defibrillators, rising awareness among cardiologists about the benefits pertaining to subcutaneous ICDs, and the launch of technologically advanced ICDs.
'Adult patients segment dominated the of the defibrillator market based on patients type in 2022'
The defibrillator market is segmented into adult and pediatric patients based on patient type. The adult patients segment dominated the global defibrillators in 2022. The increasing incidence of cardiovascular disease in the adult population, rapid growth in the geriatric population highly susceptible to sudden cardiac arrest, and the increasing number of implantation of ICDs in adult patients are likely to fuel the growth of the segment.
'North America accounted for the highest market share in the defibrillators market during the forecast period'
Based on the region, the global defibrillators market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to the factors such as the rising adoption of advanced defibrillators, increasing efforts by governments to provide the necessary care to cardiac arrest patients, the strong foothold of market players, favorable reimbursement programs, and an increase in the incidence of coronary artery diseases.
Breakdown of supply-side primary interviews by company type, designation, and region:
Research Coverage
This research report categorizes the defibrillators market by Product (Implantable cardioverter defibrillators (transvenous implantable cardioverter defibrillators {biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS, and single-chamber ICDS}, Subcutaneous implantable cardioverter defibrillators) External defibrillators (manual & semi-automated external defibrillators, fully automated external defibrillators, wearable cardioverter defibrillators), Patients type (Adult, Pediatrics), End Users (Hospitals, Clinics and Cardiac centres, Pre-hospital care settings,Public access markets, Home care settings, Alternate care facilities, and Other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the defibrillators market.
A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the defibrillators market. Competitive analysis of upcoming startups in the defibrillators market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall defibrillators market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
'Implantable Cardioverter Defibrillator segment accounted for the largest share of global defibrillator market in 2022'
Based on product , the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. ICDs are further divided into transvenous implantable cardioverter defibrillators and subcutaneous implantable cardioverter defibrillators, whereas external defibrillators are divided into manual AED, fully automated AED, and wearable defibrillator. The ICDs segment accounted for the largest global defibrillators market share in 2022. The technological advancements in implantable defibrillators, rising awareness among cardiologists about the benefits pertaining to subcutaneous ICDs, and the launch of technologically advanced ICDs.
'Adult patients segment dominated the of the defibrillator market based on patients type in 2022'
The defibrillator market is segmented into adult and pediatric patients based on patient type. The adult patients segment dominated the global defibrillators in 2022. The increasing incidence of cardiovascular disease in the adult population, rapid growth in the geriatric population highly susceptible to sudden cardiac arrest, and the increasing number of implantation of ICDs in adult patients are likely to fuel the growth of the segment.
'North America accounted for the highest market share in the defibrillators market during the forecast period'
Based on the region, the global defibrillators market is categorized into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to witness a high market share during the forecast period. This can be attributed to the factors such as the rising adoption of advanced defibrillators, increasing efforts by governments to provide the necessary care to cardiac arrest patients, the strong foothold of market players, favorable reimbursement programs, and an increase in the incidence of coronary artery diseases.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (30%), Tier 2 (45%), and Tier 3 (25%)
- By Designation: C-level (20%), Director-level (20%), and Others (45%)
- By Region: North America (40%), Asia- Pacific (30%), Europe (20%), Latin America (7%) and Middle East & Africa(3%)
Research Coverage
This research report categorizes the defibrillators market by Product (Implantable cardioverter defibrillators (transvenous implantable cardioverter defibrillators {biventricular ICDS/cardiac resynchronization therapy defibrillators, dual-chamber ICDS, and single-chamber ICDS}, Subcutaneous implantable cardioverter defibrillators) External defibrillators (manual & semi-automated external defibrillators, fully automated external defibrillators, wearable cardioverter defibrillators), Patients type (Adult, Pediatrics), End Users (Hospitals, Clinics and Cardiac centres, Pre-hospital care settings,Public access markets, Home care settings, Alternate care facilities, and Other end users), and region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the defibrillators market.
A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, and services; key strategies; Contracts, partnerships, agreements. new product & service launches, mergers and acquisitions, and recent developments associated with the defibrillators market. Competitive analysis of upcoming startups in the defibrillators market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall defibrillators market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (rising prevalence of cardiovascular disease, increase in geriatric patient population, a strong focus of government to boost the installation of public access defibrillators, rising defibrillators training & programs, and expanding healthcare infrastructure), restraints (frequent product recalls, issues related to implantable and automated external defibrillators), opportunities (emerging countries, ongoing developments in ICDs/CRT-Ds, mergers and acquisitions among market players), and challenges (frequent product recalls and lack of awareness about the cardiac arrest in emerging countries) influencing the growth of the defibrillators market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the defibrillators market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the defibrillators market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the defibrillators market
- Competitive Assessment: In-depth assessment of market shares, growth strategies and service offerings of leading players like Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US, Abbott (US)
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 MARKETS COVERED
1.3.1 GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 DEFIBRILLATORS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 6 DEFIBRILLATORS MARKET: MARKET SIZE ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 8 DEFIBRILLATORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 9 DEFIBRILLATORS MARKET, BY END USER, 2023 VS. 2028
FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2023 VS. 2028
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATORS MARKET
4 PREMIUM INSIGHTS
4.1 DEFIBRILLATORS MARKET OVERVIEW
FIGURE 12 RISING INCIDENCE OF CVD TO DRIVE MARKET
4.2 DEFIBRILLATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 IMPLANTABLE DEFIBRILLATORS TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 DEFIBRILLATORS MARKET, BY REGION AND END USER
FIGURE 14 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2022
4.4 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATORS MARKET
FIGURE 15 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cardiovascular diseases
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS, BY REGION
5.2.1.2 Growing focus on providing public-access defibrillators
5.2.1.3 Training and awareness programs on defibrillators
5.2.2 RESTRAINTS
5.2.2.1 Frequent product recalls
TABLE 3 RECENT PRODUCT RECALLS BY US FDA (2018–2023)
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
5.2.4 CHALLENGES
5.2.4.1 Inadequate awareness of sudden cardiac arrests in emerging markets
5.2.4.2 Challenges associated with pricing pressure
5.3 REIMBURSEMENT SCENARIO
TABLE 4 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US
TABLE 5 MEDICARE OUTPATIENT: NATIONAL AVERAGE PAYMENT IN US (2023)
5.4 REGULATORY LANDSCAPE
5.4.1 US
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.1 Canada
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 ASIA PACIFIC
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
TABLE 9 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
5.5 PRICING TREND ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY KEY PLAYER (2021) (USD)
TABLE 11 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY COUNTRY (USD) (2021)
5.6 PATENT ANALYSIS
FIGURE 17 TOP PATENT APPLICANTS FOR DEFIBRILLATORS DEVICES, JANUARY 2012–MAY 2023
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 MANUFACTURING & ASSEMBLY
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 19 DEFIBRILLATORS MARKET: SUPPLY CHAIN ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 OVERVIEW
TABLE 12 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.2 THREAT OF NEW ENTRANTS
5.9.3 THREAT OF SUBSTITUTES
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 BARGAINING POWER OF BUYERS
5.9.6 INTENSITY OF COMPETITIVE RIVALRY
5.10 TRADE ANALYSIS
TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
5.11 TECHNOLOGY ANALYSIS
FIGURE 20 ECOSYSTEM COVERAGE
5.12 KEY CONFERENCES AND EVENTS
TABLE 15 DEFIBRILLATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2022?2023)
5.13 CASE STUDY ANALYSIS
5.13.1 IDENTIFY IMPACT OF 4-LAYER RIGID-FLEX BOARD PCB IN DEFIBRILLATORS
TABLE 16 CASE 1: IDENTIFY IMPACT OF THIN-LAYERED PCBS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
5.14 STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCTS
5.15 KEY BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR DEFIBRILLATORS
6 DEFIBRILLATORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 21 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 23 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators
6.2.1.1.1 Launch of technologically advanced CRT-D devices to drive market
TABLE 24 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.2 Dual-chamber ICDs
6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market
TABLE 25 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.3 Single-chamber ICDs
6.2.1.3.1 Utilization in arterial monitoring to support market growth
TABLE 26 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.2.1 Benefits of eliminating cardiac leads to drive market
TABLE 27 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 EXTERNAL DEFIBRILLATORS
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 31 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.3.1 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.1.1 Initiatives for emergency medical services to support market growth
TABLE 32 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.2.1 Rising installation in public places to propel market
TABLE 33 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
6.3.3.1 Operational difficulties and false alarms to restrain market adoption
TABLE 34 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE
7.1 INTRODUCTION
TABLE 35 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
7.2 ADULT PATIENTS
7.2.1 INCREASING UTILIZATION OF PUBLIC-ACCESS DEFIBRILLATORS TO DRIVE MARKET
TABLE 36 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2021–2028 (USD MILLION)
7.3 PEDIATRIC PATIENTS
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT MARKET GROWTH
TABLE 37 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2021–2028 (USD MILLION)
8 DEFIBRILLATORS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 38 DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
8.2.1 HIGH VOLUME OF ICD PROCEDURES TO DRIVE MARKET
TABLE 39 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION)
8.3 PREHOSPITAL SETTINGS
8.3.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO DRIVE MARKET
TABLE 40 DEFIBRILLATORS MARKET FOR PREHOSPITAL SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.4 PUBLIC-ACCESS MARKETS
8.4.1 RISING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET
TABLE 41 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2021–2028 (USD MILLION)
8.5 HOME CARE SETTINGS
8.5.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO DRIVE MARKET
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.6 ALTERNATE CARE FACILITIES
8.6.1 INADEQUATE HEALTHCARE INFRASTRUCTURE TO LIMIT ADOPTION
TABLE 43 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2021–2028 (USD MILLION)
8.7 OTHER END USERS
TABLE 44 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 DEFIBRILLATORS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 45 DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 High implant rates of ICDS to drive market
TABLE 53 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 54 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High burden of CVDs to support market growth
TABLE 57 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 58 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Established healthcare system equipped with advanced cardiology devices to drive market
TABLE 68 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising support from government & private organizations for accessibility of defibrillators to drive market
TABLE 72 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 73 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 USD MILLION)
TABLE 75 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Favorable government initiatives to support market growth
TABLE 76 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High prevalence of OHCA to drive market
TABLE 80 ITALY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising awareness initiatives on defibrillators to propel market
TABLE 84 SPAIN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 85 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 88 REST OF EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 94 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 98 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Presence of universal insurance scheme in Japan to support market growth
TABLE 99 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising incidence of strokes to drive market
TABLE 103 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 104 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing acceptance of defibrillators and innovative product launches to drive market
TABLE 107 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Initiatives by government & private bodies for installation of PADs to support market growth
TABLE 111 AUSTRALIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 112 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Launch of innovative products by local players to propel market
TABLE 115 SOUTH KOREA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 116 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC (ROAPAC)
TABLE 119 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.7 ASIA PACIFIC: RECESSION IMPACT
9.5 LATIN AMERICA
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 125 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 129 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increasing obesity cases to support market growth
TABLE 130 BRAZIL: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 131 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 High prevalence of target diseases to support market growth
TABLE 134 MEXICO: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 135 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 138 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 139 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.4 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING AWARENESS INITIATIVES ON ADVANTAGES OF DEFIBRILLATORS TO SUPPORT MARKET GROWTH
TABLE 142 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.1.1 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 148 STRATEGIES ADOPTED BY KEY PLAYERS (2019?2023)
10.2 REVENUE SHARE ANALYSIS
FIGURE 25 DEFIBRILLATORS MARKET: REVENUE SHARE ANALYSIS OF PLAYERS
10.3 MARKET SHARE ANALYSIS
FIGURE 26 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER (2022)
TABLE 149 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD) MARKET: INTENSITY OF COMPETITIVE RIVALRY
TABLE 150 AUTOMATED DEFIBRILLATORS MARKET: INTENSITY OF COMPETITIVE RIVALRY
10.4 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 27 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.5 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
FIGURE 28 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS (2022)
10.6 COMPETITIVE BENCHMARKING: FOOTPRINT ANALYSIS OF LEADING PLAYERS
TABLE 151 DEFIBRILLATORS MARKET: COMPANY FOOTPRINT ANALYSIS
TABLE 152 DEFIBRILLATORS MARKET: PRODUCT FOOTPRINT ANALYSIS
TABLE 153 DEFIBRILLATORS MARKET: REGIONAL FOOTPRINT ANALYSIS
10.6.1 PRODUCT LAUNCHES & APPROVALS
TABLE 154 DEFIBRILLATORS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–APRIL 2023)
10.6.2 DEALS
TABLE 155 DEFIBRILLATORS MARKET: KEY DEALS (JANUARY 2019–APRIL 2023)
10.6.3 OTHER DEVELOPMENTS
TABLE 156 DEFIBRILLATORS MARKET: OTHER DEVELOPMENTS (JANUARY 2019–APRIL 2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MEDTRONIC
TABLE 157 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.2 STRYKER
TABLE 158 STRYKER: BUSINESS OVERVIEW
FIGURE 30 STRYKER: COMPANY SNAPSHOT (2022)
11.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 159 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.4 ASAHI KASEI CORPORATION
TABLE 160 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 BOSTON SCIENTIFIC CORPORATION
TABLE 161 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 ABBOTT
TABLE 162 ABBOTT: BUSINESS OVERVIEW
FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2022)
TABLE 163 PRODUCT APPROVALS
11.1.7 MICROPORT SCIENTIFIC CORPORATION
TABLE 164 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 165 PRODUCT APPROVALS
11.1.8 NIHON KOHDEN CORPORATION
TABLE 166 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
TABLE 167 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
FIGURE 37 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
TABLE 168 PRODUCT LAUNCHES & APPROVALS
11.1.10 BIOTRONIK
TABLE 169 BIOTRONIK: BUSINESS OVERVIEW
11.1.11 CU MEDICAL SYSTEMS CO., LTD.
TABLE 170 CU MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
11.1.12 METSIS MEDIKAL LTD.
TABLE 171 METSIS MEDIKAL LTD: BUSINESS OVERVIEW
11.1.13 MEDIANA CO. LTD.
TABLE 172 MEDIANA CO. LTD.: BUSINESS OVERVIEW
11.1.14 PROGETTI SRL
TABLE 173 PROGETTI SRL: BUSINESS OVERVIEW
11.1.15 SCHILLER AG
TABLE 174 SCHILLER AG: BUSINESS OVERVIEW
11.1.16 BPL MEDICAL TECHNOLOGIES
TABLE 175 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
11.1.17 METRAX GMBH
TABLE 176 METRAX GMBH: BUSINESS OVERVIEW
11.1.18 MS WESTFALIA GMBH
TABLE 177 MS WESTFALIA GMBH: BUSINESS OVERVIEW
11.1.19 BEXEN CARDIO
TABLE 178 BEXEN CARDIO: BUSINESS OVERVIEW
11.1.20 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
TABLE 179 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 AVIVE SOLUTIONS INC.
11.2.2 AMI ITALIA
11.2.3 CORPULS
11.2.4 ALLIED MEDICAL LTD.
11.2.5 AXION CONCERN LLC
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 STUDY SCOPE
FIGURE 1 MARKETS COVERED
1.3.1 GEOGRAPHIC SCOPE
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.7 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 2 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY RESEARCH
2.1.2.1 Key data from primary sources
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 4 DEFIBRILLATORS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION METHODOLOGY
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 PRODUCT-BASED MARKET ESTIMATION
2.2.2 END USER-BASED MARKET ESTIMATION
FIGURE 6 DEFIBRILLATORS MARKET: MARKET SIZE ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION
FIGURE 7 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH ASSUMPTIONS AND LIMITATIONS
2.4.1 RESEARCH ASSUMPTIONS
2.4.2 RESEARCH LIMITATIONS
2.5 RECESSION IMPACT
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 (% GROWTH)
3 EXECUTIVE SUMMARY
FIGURE 8 DEFIBRILLATORS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 9 DEFIBRILLATORS MARKET, BY END USER, 2023 VS. 2028
FIGURE 10 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2023 VS. 2028
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF DEFIBRILLATORS MARKET
4 PREMIUM INSIGHTS
4.1 DEFIBRILLATORS MARKET OVERVIEW
FIGURE 12 RISING INCIDENCE OF CVD TO DRIVE MARKET
4.2 DEFIBRILLATORS MARKET, BY TYPE, 2023 VS. 2028 (USD MILLION)
FIGURE 13 IMPLANTABLE DEFIBRILLATORS TO DOMINATE MARKET DURING FORECAST PERIOD
4.3 DEFIBRILLATORS MARKET, BY REGION AND END USER
FIGURE 14 HOSPITALS, CLINICS, AND CARDIAC CENTERS SEGMENT IN ASIA PACIFIC REGION ACCOUNTED FOR LARGEST SHARE IN 2022
4.4 GEOGRAPHIC SNAPSHOT OF DEFIBRILLATORS MARKET
FIGURE 15 CHINA TO WITNESS HIGHEST CAGR DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 16 DEFIBRILLATORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising prevalence of cardiovascular diseases
TABLE 2 PERCENTAGE OF POPULATION AGED 65 YEARS, BY REGION
5.2.1.2 Growing focus on providing public-access defibrillators
5.2.1.3 Training and awareness programs on defibrillators
5.2.2 RESTRAINTS
5.2.2.1 Frequent product recalls
TABLE 3 RECENT PRODUCT RECALLS BY US FDA (2018–2023)
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Development of S-ICDs and MRI-compatible ICDs & CRT-Ds
5.2.4 CHALLENGES
5.2.4.1 Inadequate awareness of sudden cardiac arrests in emerging markets
5.2.4.2 Challenges associated with pricing pressure
5.3 REIMBURSEMENT SCENARIO
TABLE 4 MEDICAL REIMBURSEMENT CODES FOR DEFIBRILLATOR PROCEDURES IN US
TABLE 5 MEDICARE OUTPATIENT: NATIONAL AVERAGE PAYMENT IN US (2023)
5.4 REGULATORY LANDSCAPE
5.4.1 US
TABLE 6 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 7 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.1 Canada
TABLE 8 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 ASIA PACIFIC
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
TABLE 9 KEY REGULATORY BODIES AND GOVERNMENT AGENCIES
5.5 PRICING TREND ANALYSIS
TABLE 10 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY KEY PLAYER (2021) (USD)
TABLE 11 AVERAGE SELLING PRICE OF DEFIBRILLATORS, BY COUNTRY (USD) (2021)
5.6 PATENT ANALYSIS
FIGURE 17 TOP PATENT APPLICANTS FOR DEFIBRILLATORS DEVICES, JANUARY 2012–MAY 2023
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & DEVELOPMENT
5.7.2 MANUFACTURING & ASSEMBLY
5.7.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 18 DEFIBRILLATORS MARKET: VALUE CHAIN ANALYSIS
5.8 SUPPLY CHAIN ANALYSIS
FIGURE 19 DEFIBRILLATORS MARKET: SUPPLY CHAIN ANALYSIS
5.9 PORTER’S FIVE FORCES ANALYSIS
5.9.1 OVERVIEW
TABLE 12 DEFIBRILLATORS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.2 THREAT OF NEW ENTRANTS
5.9.3 THREAT OF SUBSTITUTES
5.9.4 BARGAINING POWER OF SUPPLIERS
5.9.5 BARGAINING POWER OF BUYERS
5.9.6 INTENSITY OF COMPETITIVE RIVALRY
5.10 TRADE ANALYSIS
TABLE 13 IMPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
TABLE 14 EXPORT DATA FOR HS CODE 901890, BY COUNTRY, 2018–2022 (USD MILLION)
5.11 TECHNOLOGY ANALYSIS
FIGURE 20 ECOSYSTEM COVERAGE
5.12 KEY CONFERENCES AND EVENTS
TABLE 15 DEFIBRILLATORS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS (2022?2023)
5.13 CASE STUDY ANALYSIS
5.13.1 IDENTIFY IMPACT OF 4-LAYER RIGID-FLEX BOARD PCB IN DEFIBRILLATORS
TABLE 16 CASE 1: IDENTIFY IMPACT OF THIN-LAYERED PCBS IN IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
5.14 STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS
FIGURE 21 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR KEY PRODUCTS
5.15 KEY BUYING CRITERIA
FIGURE 22 KEY BUYING CRITERIA FOR DEFIBRILLATORS
6 DEFIBRILLATORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 17 DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 18 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 19 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 20 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 21 IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.2.1 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
TABLE 22 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 23 TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.1 Biventricular ICDs/Cardiac resynchronization therapy defibrillators
6.2.1.1.1 Launch of technologically advanced CRT-D devices to drive market
TABLE 24 BIVENTRICULAR ICDS/CARDIAC RESYNCHRONIZATION THERAPY DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.2 Dual-chamber ICDs
6.2.1.2.1 Ability to reduce incidence of inappropriate shocks to drive market
TABLE 25 DUAL-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.1.3 Single-chamber ICDs
6.2.1.3.1 Utilization in arterial monitoring to support market growth
TABLE 26 SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS
6.2.2.1 Benefits of eliminating cardiac leads to drive market
TABLE 27 SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 EXTERNAL DEFIBRILLATORS
TABLE 28 EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 29 EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 30 EXTERNAL DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 31 EXTERNAL DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
6.3.1 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.1.1 Initiatives for emergency medical services to support market growth
TABLE 32 SEMI-AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS
6.3.2.1 Rising installation in public places to propel market
TABLE 33 FULLY AUTOMATED EXTERNAL DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.3 WEARABLE CARDIOVERTER DEFIBRILLATORS
6.3.3.1 Operational difficulties and false alarms to restrain market adoption
TABLE 34 WEARABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
7 DEFIBRILLATORS MARKET, BY PATIENT TYPE
7.1 INTRODUCTION
TABLE 35 DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
7.2 ADULT PATIENTS
7.2.1 INCREASING UTILIZATION OF PUBLIC-ACCESS DEFIBRILLATORS TO DRIVE MARKET
TABLE 36 DEFIBRILLATORS MARKET FOR ADULT PATIENTS, BY REGION, 2021–2028 (USD MILLION)
7.3 PEDIATRIC PATIENTS
7.3.1 INCREASING INCIDENCE OF PEDIATRIC HEART AILMENTS TO SUPPORT MARKET GROWTH
TABLE 37 DEFIBRILLATORS MARKET FOR PEDIATRIC PATIENTS, BY REGION, 2021–2028 (USD MILLION)
8 DEFIBRILLATORS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 38 DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 HOSPITALS, CLINICS, AND CARDIAC CENTERS
8.2.1 HIGH VOLUME OF ICD PROCEDURES TO DRIVE MARKET
TABLE 39 DEFIBRILLATORS MARKET FOR HOSPITALS, CLINICS, AND CARDIAC CENTERS, BY REGION, 2021–2028 (USD MILLION)
8.3 PREHOSPITAL SETTINGS
8.3.1 RISING FUNDING FOR EMERGENCY AMBULANCE SERVICES TO DRIVE MARKET
TABLE 40 DEFIBRILLATORS MARKET FOR PREHOSPITAL SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.4 PUBLIC-ACCESS MARKETS
8.4.1 RISING INCIDENCE OF SUDDEN CARDIAC ARRESTS TO PROPEL MARKET
TABLE 41 DEFIBRILLATORS MARKET FOR PUBLIC-ACCESS MARKETS, BY REGION, 2021–2028 (USD MILLION)
8.5 HOME CARE SETTINGS
8.5.1 RISING ADOPTION OF HOME-AUTOMATED EXTERNAL DEFIBRILLATORS TO DRIVE MARKET
TABLE 42 DEFIBRILLATORS MARKET FOR HOME CARE SETTINGS, BY REGION, 2021–2028 (USD MILLION)
8.6 ALTERNATE CARE FACILITIES
8.6.1 INADEQUATE HEALTHCARE INFRASTRUCTURE TO LIMIT ADOPTION
TABLE 43 DEFIBRILLATORS MARKET FOR ALTERNATE CARE FACILITIES, BY REGION, 2021–2028 (USD MILLION)
8.7 OTHER END USERS
TABLE 44 DEFIBRILLATORS MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
9 DEFIBRILLATORS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 45 DEFIBRILLATORS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 23 NORTH AMERICA: DEFIBRILLATORS MARKET SNAPSHOT
TABLE 46 NORTH AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 47 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 48 NORTH AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 50 NORTH AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 51 NORTH AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 52 NORTH AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 High implant rates of ICDS to drive market
TABLE 53 US: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 54 US: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 55 US: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 56 US: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 High burden of CVDs to support market growth
TABLE 57 CANADA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 58 CANADA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 59 CANADA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 60 CANADA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.2.3 NORTH AMERICA: RECESSION IMPACT
9.3 EUROPE
TABLE 61 EUROPE: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 63 EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 65 EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 67 EUROPE: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Established healthcare system equipped with advanced cardiology devices to drive market
TABLE 68 GERMANY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 69 GERMANY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 70 GERMANY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 GERMANY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.2 UK
9.3.2.1 Rising support from government & private organizations for accessibility of defibrillators to drive market
TABLE 72 UK: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 73 UK: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 74 UK: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 USD MILLION)
TABLE 75 UK: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Favorable government initiatives to support market growth
TABLE 76 FRANCE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 77 FRANCE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 78 FRANCE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 FRANCE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 High prevalence of OHCA to drive market
TABLE 80 ITALY: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 81 ITALY: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 82 ITALY: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 83 ITALY: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising awareness initiatives on defibrillators to propel market
TABLE 84 SPAIN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 85 SPAIN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 86 SPAIN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 87 SPAIN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.6 REST OF EUROPE
TABLE 88 REST OF EUROPE: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 89 REST OF EUROPE: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 90 REST OF EUROPE: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 91 REST OF EUROPE: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.3.7 EUROPE: RECESSION IMPACT
9.4 ASIA PACIFIC
FIGURE 24 ASIA PACIFIC: DEFIBRILLATORS MARKET SNAPSHOT
TABLE 92 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 94 ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 95 ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 98 ASIA PACIFIC: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 JAPAN
9.4.1.1 Presence of universal insurance scheme in Japan to support market growth
TABLE 99 JAPAN: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 100 JAPAN: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 101 JAPAN: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 102 JAPAN: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.2 CHINA
9.4.2.1 Rising incidence of strokes to drive market
TABLE 103 CHINA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 104 CHINA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 CHINA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 106 CHINA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Growing acceptance of defibrillators and innovative product launches to drive market
TABLE 107 INDIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 108 INDIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 109 INDIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 INDIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.4 AUSTRALIA
9.4.4.1 Initiatives by government & private bodies for installation of PADs to support market growth
TABLE 111 AUSTRALIA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 112 AUSTRALIA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 AUSTRALIA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 114 AUSTRALIA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.5 SOUTH KOREA
9.4.5.1 Launch of innovative products by local players to propel market
TABLE 115 SOUTH KOREA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 116 SOUTH KOREA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 117 SOUTH KOREA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 118 SOUTH KOREA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.6 REST OF ASIA PACIFIC (ROAPAC)
TABLE 119 REST OF ASIA PACIFIC: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 120 REST OF ASIA PACIFIC: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 REST OF ASIA PACIFIC: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 122 REST OF ASIA PACIFIC: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.4.7 ASIA PACIFIC: RECESSION IMPACT
9.5 LATIN AMERICA
TABLE 123 LATIN AMERICA: DEFIBRILLATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 125 LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 LATIN AMERICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 129 LATIN AMERICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5.1 BRAZIL
9.5.1.1 Increasing obesity cases to support market growth
TABLE 130 BRAZIL: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 131 BRAZIL: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 BRAZIL: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 133 BRAZIL: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.2 MEXICO
9.5.2.1 High prevalence of target diseases to support market growth
TABLE 134 MEXICO: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 135 MEXICO: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 MEXICO: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 MEXICO: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.3 REST OF LATIN AMERICA
TABLE 138 REST OF LATIN AMERICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 139 REST OF LATIN AMERICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 140 REST OF LATIN AMERICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 REST OF LATIN AMERICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
9.5.4 LATIN AMERICA: RECESSION IMPACT
9.6 MIDDLE EAST & AFRICA
9.6.1 GROWING AWARENESS INITIATIVES ON ADVANTAGES OF DEFIBRILLATORS TO SUPPORT MARKET GROWTH
TABLE 142 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
TABLE 143 MIDDLE EAST & AFRICA: IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 144 MIDDLE EAST & AFRICA: TRANSVENOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 MIDDLE EAST & AFRICA: EXTERNAL DEFIBRILLATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY PATIENT TYPE, 2021–2028 (USD MILLION)
TABLE 147 MIDDLE EAST & AFRICA: DEFIBRILLATORS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.1.1 STRATEGIES ADOPTED BY KEY PLAYERS
TABLE 148 STRATEGIES ADOPTED BY KEY PLAYERS (2019?2023)
10.2 REVENUE SHARE ANALYSIS
FIGURE 25 DEFIBRILLATORS MARKET: REVENUE SHARE ANALYSIS OF PLAYERS
10.3 MARKET SHARE ANALYSIS
FIGURE 26 DEFIBRILLATORS MARKET SHARE, BY KEY PLAYER (2022)
TABLE 149 IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICD) MARKET: INTENSITY OF COMPETITIVE RIVALRY
TABLE 150 AUTOMATED DEFIBRILLATORS MARKET: INTENSITY OF COMPETITIVE RIVALRY
10.4 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.4.1 STARS
10.4.2 EMERGING LEADERS
10.4.3 PERVASIVE PLAYERS
10.4.4 PARTICIPANTS
FIGURE 27 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX (2022)
10.5 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES (2022)
10.5.1 PROGRESSIVE COMPANIES
10.5.2 RESPONSIVE COMPANIES
10.5.3 DYNAMIC COMPANIES
10.5.4 STARTING BLOCKS
FIGURE 28 DEFIBRILLATORS MARKET: COMPANY EVALUATION MATRIX FOR SMES/STARTUPS (2022)
10.6 COMPETITIVE BENCHMARKING: FOOTPRINT ANALYSIS OF LEADING PLAYERS
TABLE 151 DEFIBRILLATORS MARKET: COMPANY FOOTPRINT ANALYSIS
TABLE 152 DEFIBRILLATORS MARKET: PRODUCT FOOTPRINT ANALYSIS
TABLE 153 DEFIBRILLATORS MARKET: REGIONAL FOOTPRINT ANALYSIS
10.6.1 PRODUCT LAUNCHES & APPROVALS
TABLE 154 DEFIBRILLATORS MARKET: PRODUCT LAUNCHES & APPROVALS (JANUARY 2019–APRIL 2023)
10.6.2 DEALS
TABLE 155 DEFIBRILLATORS MARKET: KEY DEALS (JANUARY 2019–APRIL 2023)
10.6.3 OTHER DEVELOPMENTS
TABLE 156 DEFIBRILLATORS MARKET: OTHER DEVELOPMENTS (JANUARY 2019–APRIL 2023)
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products Offered, Recent Developments, and MnM View)*
11.1.1 MEDTRONIC
TABLE 157 MEDTRONIC: BUSINESS OVERVIEW
FIGURE 29 MEDTRONIC: COMPANY SNAPSHOT (2022)
11.1.2 STRYKER
TABLE 158 STRYKER: BUSINESS OVERVIEW
FIGURE 30 STRYKER: COMPANY SNAPSHOT (2022)
11.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 159 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW
FIGURE 31 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
11.1.4 ASAHI KASEI CORPORATION
TABLE 160 ASAHI KASEI CORPORATION: BUSINESS OVERVIEW
FIGURE 32 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT (2022)
11.1.5 BOSTON SCIENTIFIC CORPORATION
TABLE 161 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 33 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 ABBOTT
TABLE 162 ABBOTT: BUSINESS OVERVIEW
FIGURE 34 ABBOTT: COMPANY SNAPSHOT (2022)
TABLE 163 PRODUCT APPROVALS
11.1.7 MICROPORT SCIENTIFIC CORPORATION
TABLE 164 MICROPORT SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
FIGURE 35 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 165 PRODUCT APPROVALS
11.1.8 NIHON KOHDEN CORPORATION
TABLE 166 NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW
FIGURE 36 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)
11.1.9 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
TABLE 167 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: BUSINESS OVERVIEW
FIGURE 37 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY SNAPSHOT (2021)
TABLE 168 PRODUCT LAUNCHES & APPROVALS
11.1.10 BIOTRONIK
TABLE 169 BIOTRONIK: BUSINESS OVERVIEW
11.1.11 CU MEDICAL SYSTEMS CO., LTD.
TABLE 170 CU MEDICAL SYSTEMS CO., LTD.: BUSINESS OVERVIEW
11.1.12 METSIS MEDIKAL LTD.
TABLE 171 METSIS MEDIKAL LTD: BUSINESS OVERVIEW
11.1.13 MEDIANA CO. LTD.
TABLE 172 MEDIANA CO. LTD.: BUSINESS OVERVIEW
11.1.14 PROGETTI SRL
TABLE 173 PROGETTI SRL: BUSINESS OVERVIEW
11.1.15 SCHILLER AG
TABLE 174 SCHILLER AG: BUSINESS OVERVIEW
11.1.16 BPL MEDICAL TECHNOLOGIES
TABLE 175 BPL MEDICAL TECHNOLOGIES: BUSINESS OVERVIEW
11.1.17 METRAX GMBH
TABLE 176 METRAX GMBH: BUSINESS OVERVIEW
11.1.18 MS WESTFALIA GMBH
TABLE 177 MS WESTFALIA GMBH: BUSINESS OVERVIEW
11.1.19 BEXEN CARDIO
TABLE 178 BEXEN CARDIO: BUSINESS OVERVIEW
11.1.20 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.
TABLE 179 SHENZHEN COMEN MEDICAL INSTRUMENTS LTD.: BUSINESS OVERVIEW
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
11.2 OTHER PLAYERS
11.2.1 AVIVE SOLUTIONS INC.
11.2.2 AMI ITALIA
11.2.3 CORPULS
11.2.4 ALLIED MEDICAL LTD.
11.2.5 AXION CONCERN LLC
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
